| OSAKA Study Results met Primary Endpoint and Show That Both ADVAGRAF(R) and ... - istockAnalyst.com (press release) |
|
|
istockAnalyst.com (press release) Renal function was similar on tacrolimus prolonged release- and immediate release-based therapies. Interestingly, the study also showed that a higher starting dose of tacrolimus QD (0.3mg/kg/day) is not associated with increased efficacy. |